The fluctuation of free amino acids in serum during acute ischemic stroke

1. Brasse-Lagnel C. et al.: Glutamine stimulates argininosuccinate synthetase gene expression through cytosolic O-glycosylation of Sp1 in Caco-2 cells. J Biol Chem., 278, 52504, 2003.10.1074/jbc.M30675220014570901Search in Google Scholar

2. Castillo J., Rodriguez I.: Biochemical changes and inflammatory response as markers for brain ischaemia: molecular markers of diagnostic utility and prognosis in human clinical practice. Cerebrovasc Dis., 17 Suppl 1, 7, 2004.10.1159/00007479114694276Search in Google Scholar

3. Harston, George W J et al.: The contribution of L-arginine to the neurotoxicity of recombinant tissue plasminogen activator following cerebral ischemia: a review of rtPA neurotoxicity. J Cereb Blood Flow Metab., 30, 1804, 2010.Search in Google Scholar

4. Horecka A. et al.: Actylise treatment does not influence nitric oxide metabolites serum level. Pharmacol Rep, 2016.10.1016/j.pharep.2015.12.01026971035Search in Google Scholar

5. Huang Y.F., Wang Y., Watford M.: Glutamine directly downregulates glutamine synthetase protein levels in mouse C2C12 skeletal muscle myotubes. J Nutr., 137, 1357, 2007.Search in Google Scholar

6. Karna E., Szoka L., Palka J.A.: Captopril-dependent inhibition of collagen biosynthesis in cultured fibroblasts. Pharmazie., 65, 614, 2010.Search in Google Scholar

7. Kimberly W.T. et al.: Metabolite profiling identifies a branched chain amino acid signature in acute cardioembolic stroke. Stroke., 44, 1389, 2013.10.1161/STROKEAHA.111.000397381608923520238Search in Google Scholar

8. Kuklina E.V. et al.: Epidemiology and prevention of stroke: a worldwide perspective. Expert Rev Neurother., 12, 199, 2012.10.1586/ern.11.99447858922288675Search in Google Scholar

9. Kurzepa J. et al.: Thrombolytic treatment decreases glutamate/GABA ratio in serum during acute ischaemic stroke: a pilot study. Neurol Res., 37, 934, 2015.10.1179/1743132815Y.000000004926005019Search in Google Scholar

10. Miao Y., Liao J.K.: Potential serum biomarkers in the pathophysiological processes of stroke. Expert Rev Neurother., 14, 173, 2014.Search in Google Scholar

11. Nagata C. et al.: Dietary intakes of glutamic Acid and glycine are associated with stroke mortality in Japanese adults. J Nutr., 145, 720, 2015.10.3945/jn.114.20129325833775Search in Google Scholar

12. Newsholme P. et al.: New insights into amino acid metabolism, beta-cell function and diabetes. Clin Sci (Lond)., 108, 185, 2005.10.1042/CS2004029015544573Search in Google Scholar

13. Phang J.M. et al.: Proline metabolism and cancer: emerging links to glutamine and collagen. Curr Opin Clin Nutr Metab Care., 18, 71, 2015.10.1097/MCO.0000000000000121425575925474014Search in Google Scholar

14. Raman K., Pare G.: Of stroke and biomarkers: the elusive quest for a clinical biomarker panel. Clin Biochem., 46, 705, 2013.Search in Google Scholar

15. Salemi G. et al.: Blood levels of homocysteine, cysteine, glutathione, folic acid, and vitamin B12 in the acute phase of atherothrombotic stroke. Neurol Sci., 30, 361, 2009.Search in Google Scholar

16. Skovierova H. et al.: Effect of homocysteine on survival of human glial cells. Physiol Res, 2015.10.33549/physiolres.93289725804098Search in Google Scholar

17. Staszewski J. et al.: Intravenous insulin therapy in the maintenance of strict glycemic control in nondiabetic acute stroke patients with mild hyperglycemia. J Stroke Cerebrovasc Dis., 20, 150, 2011.10.1016/j.jstrokecerebrovasdis.2009.11.01320621520Search in Google Scholar

18. Szpetnar M., Pasternak K., Boguszewska A.: Branched chain amino acids (BCAAs) in heart diseases (ischaemic heart disease and myocardial infarction). Ann Univ Mariae Curie Sklodowska Med., 59, 91, 2004.Search in Google Scholar

19. Takemoto Y.: Intracisternally injected L-proline activates hypothalamic supraoptic, but not paraventricular, vasopressin-expressing neurons in conscious rats. J Amino Acids., 2011, 230613, 2011.10.4061/2011/230613326803422312458Search in Google Scholar

20. Tom A., Nair K.S.: Assessment of branched-chain amino Acid status and potential for biomarkers. J Nutr., 136, 324S-30S, 2006.10.1093/jn/136.1.324S16365107Search in Google Scholar

21. Watford M.: Lowered concentrations of branched-chain amino acids result in impaired growth and neurological problems: insights from a branched-chain alpha-keto acid dehydrogenase complex kinase-deficient mouse model. Nutr Rev., 65, 167, 2007.10.1301/nr.2007.apr.167-172Search in Google Scholar

22. Wong, Peter T H et al.: High plasma cyst(e)ine level may indicate poor clinical outcome in patients with acute stroke: possible involvement of hydrogen sulfide. J Neuropathol Exp Neurol., 65, 109, 2006.Search in Google Scholar

23. Wu G.: Amino acids: metabolism, functions, and nutrition. Amino Acids., 37, 1, 2009.Search in Google Scholar

24. Wu G. et al.: Arginine metabolism and nutrition in growth, health and disease. Amino Acids., 37, 153, 2009.10.1007/s00726-008-0210-y267711619030957Search in Google Scholar